1. Home
  2. INVE vs QNCX Comparison

INVE vs QNCX Comparison

Compare INVE & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • QNCX
  • Stock Information
  • Founded
  • INVE 1990
  • QNCX 2012
  • Country
  • INVE United States
  • QNCX United States
  • Employees
  • INVE N/A
  • QNCX N/A
  • Industry
  • INVE Computer peripheral equipment
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INVE Technology
  • QNCX Health Care
  • Exchange
  • INVE Nasdaq
  • QNCX Nasdaq
  • Market Cap
  • INVE 87.4M
  • QNCX 92.3M
  • IPO Year
  • INVE 1997
  • QNCX 2019
  • Fundamental
  • Price
  • INVE $3.74
  • QNCX $1.66
  • Analyst Decision
  • INVE Strong Buy
  • QNCX Strong Buy
  • Analyst Count
  • INVE 2
  • QNCX 4
  • Target Price
  • INVE $7.25
  • QNCX $9.50
  • AVG Volume (30 Days)
  • INVE 45.6K
  • QNCX 147.2K
  • Earning Date
  • INVE 03-11-2025
  • QNCX 11-13-2024
  • Dividend Yield
  • INVE N/A
  • QNCX N/A
  • EPS Growth
  • INVE N/A
  • QNCX N/A
  • EPS
  • INVE 3.10
  • QNCX N/A
  • Revenue
  • INVE $104,217,000.00
  • QNCX N/A
  • Revenue This Year
  • INVE N/A
  • QNCX N/A
  • Revenue Next Year
  • INVE N/A
  • QNCX N/A
  • P/E Ratio
  • INVE $1.23
  • QNCX N/A
  • Revenue Growth
  • INVE 70.57
  • QNCX N/A
  • 52 Week Low
  • INVE $2.95
  • QNCX $0.51
  • 52 Week High
  • INVE $9.24
  • QNCX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • INVE 49.51
  • QNCX 40.36
  • Support Level
  • INVE $3.44
  • QNCX $1.70
  • Resistance Level
  • INVE $3.78
  • QNCX $1.78
  • Average True Range (ATR)
  • INVE 0.19
  • QNCX 0.13
  • MACD
  • INVE 0.01
  • QNCX -0.03
  • Stochastic Oscillator
  • INVE 69.77
  • QNCX 2.56

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

Share on Social Networks: